Cellular Dynamics Gets Non-Exclusive License To Japanese Stem Cell Portfolio | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The stem cell technologies company Cellular Dynamics International announced today that it has entered into a non-exclusive licensing agreement with iPS Academia Japan, giving it access to a patented induced pluripotent stem cell portfolio based on research by Shinya Yamanaka at Kyoto University's Center for iPS Cell Research and Application.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.